Literature DB >> 19339350

Interleukin-12 (IL-12), but not IL-23, deficiency ameliorates viral encephalitis without affecting viral control.

Parul Kapil1, Roscoe Atkinson, Chandran Ramakrishna, Daniel J Cua, Cornelia C Bergmann, Stephen A Stohlman.   

Abstract

The relative contributions of interleukin-12 (IL-12) and IL-23 to viral pathogenesis have not been extensively studied. IL-12p40 mRNA rapidly increases after neurotropic coronavirus infection. Infection of mice defective in both IL-12 and IL-23 (p40(-/-)), in IL-12 alone (p35(-/-)), and in IL-23 alone (p19(-/-)) revealed that the symptoms of coronavirus-induced encephalitis are regulated by IL-12. IL-17-producing cells never exceeded background levels, supporting a redundant role of IL-23 in pathogenesis. Viral control, tropism, and demyelination were all similar in p35(-/-), p19(-/-), and wild-type mice. Reduced morbidity in infected IL-12 deficient mice was also not associated with altered recruitment or composition of inflammatory cells. However, gamma interferon (IFN-gamma) levels and virus-specific IFN-gamma-secreting CD4 and CD8 T cells were all reduced in the central nervous systems (CNS) of infected p35(-/-) mice. Transcription of the proinflammatory cytokines IL-1beta and IL-6, but not tumor necrosis factor, were initially reduced in infected p35(-/-) mice but increased to wild-type levels during peak inflammation. Furthermore, although transforming growth factor beta mRNA was not affected, IL-10 was increased in the CNS in the absence of IL-12. These data suggest that IL-12 does not contribute to antiviral function within the CNS but enhances morbidity associated with viral encephalitis by increasing the ratio of IFN-gamma to protective IL-10.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19339350      PMCID: PMC2687402          DOI: 10.1128/JVI.00315-09

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  51 in total

1.  Inverted immunodominance and impaired cytolytic function of CD8+ T cells during viral persistence in the central nervous system.

Authors:  C C Bergmann; J D Altman; D Hinton; S A Stohlman
Journal:  J Immunol       Date:  1999-09-15       Impact factor: 5.422

Review 2.  New IL-12-family members: IL-23 and IL-27, cytokines with divergent functions.

Authors:  Christopher A Hunter
Journal:  Nat Rev Immunol       Date:  2005-07       Impact factor: 53.106

3.  Mice lacking IL-12 develop polarized Th1 cells during viral infection.

Authors:  V E Schijns; B L Haagmans; C M Wierda; B Kruithof; I A Heijnen; G Alber; M C Horzinek
Journal:  J Immunol       Date:  1998-04-15       Impact factor: 5.422

4.  Role of interleukin-12 in primary influenza virus infection.

Authors:  J M Monteiro; C Harvey; G Trinchieri
Journal:  J Virol       Date:  1998-06       Impact factor: 5.103

5.  Expression of matrix metalloproteinases and their tissue inhibitor during viral encephalitis.

Authors:  Jiehao Zhou; Norman W Marten; Cornelia C Bergmann; Wendy B Macklin; David R Hinton; Stephen A Stohlman
Journal:  J Virol       Date:  2005-04       Impact factor: 5.103

Review 6.  IL-12 and IFN-gamma in host defense against mycobacteria and salmonella in mice and men.

Authors:  E Jouanguy; R Döffinger; S Dupuis; A Pallier; F Altare; J L Casanova
Journal:  Curr Opin Immunol       Date:  1999-06       Impact factor: 7.486

7.  IFN-gamma is required for viral clearance from central nervous system oligodendroglia.

Authors:  B Parra; D R Hinton; N W Marten; C C Bergmann; M T Lin; C S Yang; S A Stohlman
Journal:  J Immunol       Date:  1999-02-01       Impact factor: 5.422

8.  IL-12 is not required for induction of type 1 cytokine responses in viral infections.

Authors:  A Oxenius; U Karrer; R M Zinkernagel; H Hengartner
Journal:  J Immunol       Date:  1999-01-15       Impact factor: 5.422

Review 9.  IL-12 and IL-23: master regulators of innate and adaptive immunity.

Authors:  Claire L Langrish; Brent S McKenzie; Nicholas J Wilson; Rene de Waal Malefyt; Robert A Kastelein; Daniel J Cua
Journal:  Immunol Rev       Date:  2004-12       Impact factor: 12.988

10.  Two roads diverged: interferon alpha/beta- and interleukin 12-mediated pathways in promoting T cell interferon gamma responses during viral infection.

Authors:  L P Cousens; R Peterson; S Hsu; A Dorner; J D Altman; R Ahmed; C A Biron
Journal:  J Exp Med       Date:  1999-04-19       Impact factor: 14.307

View more
  37 in total

1.  Development of autoimmune diabetes in the absence of detectable IL-17A in a CD8-driven virally induced model.

Authors:  Tom L Van Belle; Enric Esplugues; Jeanette Liao; Therese Juntti; Richard A Flavell; Matthias G von Herrath
Journal:  J Immunol       Date:  2011-08-10       Impact factor: 5.422

2.  Enhanced antiviral T cell function in the absence of B7-H1 is insufficient to prevent persistence but exacerbates axonal bystander damage during viral encephalomyelitis.

Authors:  Timothy W Phares; Stephen A Stohlman; David R Hinton; Roscoe Atkinson; Cornelia C Bergmann
Journal:  J Immunol       Date:  2010-09-27       Impact factor: 5.422

3.  CXCR3-dependent plasma blast migration to the central nervous system during viral encephalomyelitis.

Authors:  Cristina P Marques; Parul Kapil; David R Hinton; Claudia Hindinger; Stephen L Nutt; Richard M Ransohoff; Timothy W Phares; Stephen A Stohlman; Cornelia C Bergmann
Journal:  J Virol       Date:  2011-04-20       Impact factor: 5.103

4.  CD4 T cells promote CD8 T cell immunity at the priming and effector site during viral encephalitis.

Authors:  Timothy W Phares; Stephen A Stohlman; Mihyun Hwang; Booki Min; David R Hinton; Cornelia C Bergmann
Journal:  J Virol       Date:  2011-12-28       Impact factor: 5.103

5.  Highly activated cytotoxic CD8 T cells express protective IL-10 at the peak of coronavirus-induced encephalitis.

Authors:  Kathryn Trandem; Jingxian Zhao; Erica Fleming; Stanley Perlman
Journal:  J Immunol       Date:  2011-02-11       Impact factor: 5.422

Review 6.  The pathogenesis of murine coronavirus infection of the central nervous system.

Authors:  Thomas E Lane; Martin P Hosking
Journal:  Crit Rev Immunol       Date:  2010       Impact factor: 2.214

7.  Virally expressed interleukin-10 ameliorates acute encephalomyelitis and chronic demyelination in coronavirus-infected mice.

Authors:  Kathryn Trandem; Qiushuang Jin; Kayla A Weiss; Britnie R James; Jingxian Zhao; Stanley Perlman
Journal:  J Virol       Date:  2011-05-18       Impact factor: 5.103

8.  Control of early Theiler's murine encephalomyelitis virus replication in macrophages by interleukin-6 occurs in conjunction with STAT1 activation and nitric oxide production.

Authors:  Tyler C Moore; Katherine L Bush; Liz Cody; Deborah M Brown; Thomas M Petro
Journal:  J Virol       Date:  2012-07-25       Impact factor: 5.103

9.  IL-27 limits central nervous system viral clearance by promoting IL-10 and enhances demyelination.

Authors:  Maria Teresa P de Aquino; Parul Kapil; David R Hinton; Timothy W Phares; Shweta S Puntambekar; Carine Savarin; Cornelia C Bergmann; Stephen A Stohlman
Journal:  J Immunol       Date:  2014-06-02       Impact factor: 5.422

10.  Gamma interferon signaling in oligodendrocytes is critical for protection from neurotropic coronavirus infection.

Authors:  Gabriel I Parra; Cornelia C Bergmann; Timothy W Phares; David R Hinton; Roscoe Atkinson; Stephen A Stohlman
Journal:  J Virol       Date:  2009-12-30       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.